BETHESDA, MD — Nora Volkow, the federal government’s top drug addiction researcher, laughed when asked how a spate of recent policy changes at the National Institutes of Health had affected her day-to-day work.
“They have increased my blood pressure and heart rate,” Volkow said before declining to answer specific questions about Trump administration policy changes, instead referring them to the Department of Health and Human Services, the NIH’s parent agency.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in